China
Africa
Explore chapters and articles related to this topic
The mind-body connection: patients with somatic complaints with no organic cause
Published in Julie M Schirmer MSW, Alain J Montegut MD, Stephen J Spann MD, Gabriel Ivbijaro MD, Alfred Loh MD, Behavioral Medicine in Primary Care, 2017
Julie M Schirmer, Au Bich Thuy
The second scenario takes place in China and is typical of shenjing shuairou or neurasthenia, commonly seen in Asian countries, where physical diagnoses are much more acceptable than psychological causes of functional impairment.4 It is described as a decrease in vital energy (qi). The Chinese Classification of Mental Disorders (CCMD-2) states that three of the following five symptoms are required: weakness, emotional disturbance, excitement, tension-induced pain, and sleep disturbance.5 This disorder overlaps with the Western medical diagnoses of somatization disorder, depression, anxiety, and chronic fatigue syndrome.
Mental health in mainland China
Published in Dinesh Bhugra, Samson Tse, Roger Ng, Nori Takei, Routledge Handbook of Psychiatry in Asia, 2015
Yueqin Huang, Hong Wang, Zhaorui Liu
Under the leadership of the Ministry of Health, the seven-region epidemiological survey of mental disorders was completed in 1993 in seven of the same 12 regions examined in 1982. Like the 1982 survey, this survey was supported by the WHO. The study methods and procedures were similar, but several new instruments were added, including the Negative Symptom Assessment Scale, the Wechsler Intelligence Scale for Children (WISC), the Adult Intelligence Disability Assessment Instrument, the Chinese Classification of Mental Disorders-Second Version (CCMD-2), ICD-10 and the instruments as well as tables used in the International Collaboration Research for Schizophrenia. As in the 1982 survey, each participating center studied 500 rural and 500 urban households. The final total sample was therefore 7,000 households, with 23,333 persons.
Gut metagenomic characteristics of ADHD reveal low Bacteroides ovatus-associated host cognitive impairment
Published in Gut Microbes, 2022
Yan Li, Haiting Sun, Yufen Huang, Anqi Yin, Linjuan Zhang, Jiao Han, Yixuan Lyu, Xiangzhao Xu, Yifang Zhai, Huan Sun, Ping Wang, Jinyang Zhao, Silong Sun, Hailong Dong, Feng Zhu, Qiang Wang, Luis Augusto Rohde, Xuefeng Xie, Xin Sun, Lize Xiong
A total of 207 Chinese children and adolescents, consisting of 98 patients with ADHD (Y = 9.0 years, SD = 2.0) and 109 HCs (Y = 8.9 years, SD = 1.8), were recruited. All case and control samples were collected at Xijing Hospital, Shaanxi, China, between March 20, 2018, and February 27, 2020. Patients were diagnosed and grouped by two experienced child psychiatrists using a structured diagnostic interview conducted according to the criteria of the clinical Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) and the guidelines of the Chinese classification of mental disorders (CCMD-3). The numbers of participants in the three different subgroups were 38 I-ADHD patients, 53 C-ADHD patients and 7 HI-ADHD patients. Patients with ADHD and HCs had to meet the following criteria: (1) age between 6 and 15 years; (2) no use of any antibiotic treatment for at least three months before sample collection; and (3) no history of treatment with any medication for ADHD. Participants who had other psychiatric or neurological diseases and any gastrointestinal or metabolic disorders were excluded. Children and adolescents whose IQs were below 70 according to the Wechsler Intelligence Scale were also excluded. All participants provided written informed consent, and the study was approved by the ethics committee of Xijing Hospital, Fourth Military Medical University (ID: KY20182002-1). The present study was registered at ClinicalTrials.gov (ID: NCT03447223).
Childhood Adversities in Narcissistic Personality Disorder in China
Published in Psychiatry, 2021
Ying Qiao, JunJie Wang, Li Hui, JiJun Wang, LinLin Zhou, Yi Qiao, TianHong Zhang
The controversy surrounding the diagnostic classification of personality disorder (PD) in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5; American Psychiatric Association, 2013), has garnered little attention and debate in the Chinese psychiatric field. Few articles published in the Chinese literature have addressed the DSM-5 PD classification, especially for narcissistic personality disorder (NPD), which generally has been overlooked in Chinese clinical practice. NPD is characterized by distinct personality features of exaggerating (in fantasy or behavior), requiring praise, and lacking empathy (Caligor et al., 2015). In the Chinese Classification of Mental Disorders, Third Edition (CCMD-3), published in 2001, NPD was classified as a category of other or unspecified personality disorders. Therefore, the current situation of NPD diagnosis in China results in this category being completely overlooked under the current diagnostic system.
Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials
Published in International Journal of Psychiatry in Clinical Practice, 2019
Kah Kheng Goh, Chun-Hsin Chen, Mong-Liang Lu
We included randomised controlled trials, both double-blinded and open label designs, with controlled comparison group of topiramate intervention (combination, augmentation or add-on) in patients with schizophrenia spectrum and other psychotic disorders (schizophrenia, schizoaffective disorder, brief psychotic disorder, schizophreniform disorder and delusional disorder) treated with SGAs with measurement of body weight or BMI as primary or secondary outcomes. Intervention groups were those treated with topiramate at fixed-dose or variable-dose. Comparison groups were those treated with placebo or those with no treatment. The context of the studies was not restricted to outpatients or inpatients as long as outcomes measurement were able to be completed. SGAs included amisulpride, aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone and ziprasidone. Schizophrenia spectrum and other psychotic disorders are defined and diagnosed through any recognised diagnostic criteria such as the Diagnostic and Statistical Manual of Mental Disorders (DSM), the International Statistical Classification of Diseases and Related Health Problem (ICD) and the Chinese Classification of Mental Disorders (CCMD) (Chen, 2002) were verified.